Global Compounding Pharmacy Market Growth (Status and Outlook) 2025-2031

Global Compounding Pharmacy Market Growth (Status and Outlook) 2025-2031

The global Compounding Pharmacy market size is predicted to grow from US$ 11930 million in 2025 to US$ 14080 million in 2031; it is expected to grow at a CAGR of 2.8% from 2025 to 2031.

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients. Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.

The key drivers in the compounding pharmacy market is the increasing demand for personalized medications. As healthcare becomes more tailored to individual patient needs, there is a growing preference for custom formulations, especially for those who are allergic to standard treatments, require specific dosages, or need medications that have been discontinued. Compounding pharmacies offer a solution by creating medications that are not available in mass production, meeting the unique requirements of patients, which significantly boosts market growth.However, the market faces significant challenges, primarily in the form of stringent regulatory standards. Compounded drugs are not subject to the same FDA approval process as mass-produced medications, which raises concerns about safety, efficacy, and quality control. Additionally, the cost and complexity of maintaining compliance with state and federal regulations can be a barrier for smaller pharmacies, limiting market expansion and innovation.

Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%. North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent. In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.

LPI (LP Information)' newest research report, the “Compounding Pharmacy Industry Forecast” looks at past sales and reviews total world Compounding Pharmacy sales in 2024, providing a comprehensive analysis by region and market sector of projected Compounding Pharmacy sales for 2025 through 2031. With Compounding Pharmacy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Compounding Pharmacy industry.

This Insight Report provides a comprehensive analysis of the global Compounding Pharmacy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Compounding Pharmacy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Compounding Pharmacy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Compounding Pharmacy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Compounding Pharmacy.

This report presents a comprehensive overview, market shares, and growth opportunities of Compounding Pharmacy market by product type, application, key players and key regions and countries.

Segmentation by Type:
PIA
PAA
CUPM
PDA
SAPM

Segmentation by Application:
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla Pharmacy&Stores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy

Please note: The report will take approximately 2 business days to prepare and deliver.